SEARCH

SEARCH BY CITATION

References

  • 1
    Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996; 81: 34416.
  • 2
    Patschan D, Loddenkemper K, Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 2001; 29: 498505.
  • 3
    van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Mineral Res 2000; 15: 9931000.
  • 4
    van Staa TP, Leufkens HGM, Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Mineral Res 2001; 16: 5818.
  • 5
    van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002; 13: 77787.
  • 6
    Suissa S, Baltzan M, Kremer R, Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004; 169: 838.
  • 7
    van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HGM. Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol 2001; 51: 6017.
  • 8
    van Staa TP, Leufkens HGM, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM 2000; 93: 10511.
  • 9
    Hubbard RB, Smith CJP, Smeeth L, Harrison TW, Tattersfield AE. Inhaled corticosteroids and hip fracture: a population-based case–control study. Am J Respir Crit Care Med 2002; 166: 15636.
  • 10
    Vestergaard P, Olsen ML, Johnsen SP, Rejnmark L, Sørensen HT, Mosekilde L. Corticosteroid use and risk of hip fracture: a population-based case–control study in Denmark. J Intern Med 2003; 254: 48693.
  • 11
    van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003; 125: 15917.
  • 12
    van Staa TP, Bishop N, Leufkens HG, Cooper C. Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporos Int 2004; 15: 78591.
  • 13
    Edsbacker S, Andersson T. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. Clin Pharmacokinet 2004; 43: 80321.
  • 14
    Tromm A, Mollmann H, Barth J et al. Pharmacokinetics and rectal bioavailability of hydrocortisone acetate after single and multiple administration in healthy subjects and patients. J Clin Pharmacol 2001; 41: 53641.
  • 15
    Daley-Yates PT, Kunka RL, Yin Y, Andrews SM, Callejas S, Ng C. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol 2004; 60: 2658.
  • 16
    Mizuchi A, Miyachi Y, Tamaki K, Kukita A. Percutaneous absorption of betamethasone 17-benzoate measured by radioimmunoassay. J Invest Dermatol 1976; 67: 27982.
  • 17
    Dahlstrom K, Thorsson L, Larsson P, Nikander K. Systemic availability and lung deposition of budesonide via three different nebulizers in adults. Ann Allergy Asthma Immunol 2003; 90: 22632.
  • 18
    Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001; 164: 52135.
  • 19
    Singh SD, Whale C, Houghton N, Daley-Yates P, Kirby SM, Woodcock AA. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease. Br J Clin Pharmacol 2003; 55: 37581.
  • 20
    Pouw EM, Prummel MF, Oosting H, Roos CM, Endert E. Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ 1991; 302: 6278.
  • 21
    Wong CA, Walsh LJ, Smith CJ et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000; 355: 1399403.
  • 22
    Laan RF, van Riel PL, van de Putte LB, van Erning LJ, Van't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomised controlled study. Ann Intern Med 1993; 119: 9638.
  • 23
    Vestergaard P, Emborg C, Støving RK, Hagen C, Mosekilde L, Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders – a nation-wide register study. Int J Eating Disord 2002; 32: 3018.
  • 24
    Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of anti-epileptic drugs. Epilepsia 2004; 45: 13307.
  • 25
    Jones S, Johansen A, Brennan J, Butler J, Lyons RA. The effect of socioeconomic deprivation on fracture incidence in the United Kingdom. Osteoporos Int 2004; 15: 5204.
  • 26
    Cooper C, Carbone L, Michet CJ, Atkinson EJ, O'Fallon WM, Melton LJ III. Fracture risk in patients with ankylosing spondylitis: a population-based study. J Rheumatol 1994; 21: 187782.
  • 27
    Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995; 54: 4952.
  • 28
    Abildgaard N, Brixen K, Kristensen JE, Vejlgaard T, Charles P, Nielsen JL. Assessment of bone involvement in patients with multiple myeloma using bone densitometry. Eur J Haematol 1996; 57: 3706.
  • 29
    Vestergaard P, Mosekilde L. Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 2002; 156: 110.
  • 30
    Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 72139.
  • 31
    Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999; 99: 26975.
  • 32
    Jones G, Nguyen T, Sambrook PN, Eisman JA. Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res 1995; 10: 10611.
  • 33
    Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ Jr. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 3639.
  • 34
    Ensrud KE, Blackwell T, Mangione CM et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003; 163: 94957.
  • 35
    Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. Dan Med Bull 1999; 46: 2638.
  • 36
    Munk-Jørgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997; 44: 824.
  • 37
    Mosbech J, Jørgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. The Danish National Patient Register: evaluation of data quality. Ugeskr Læger 1995; 157: 37415.
  • 38
    Vestergaard P, Mosekilde L. Fracture risk associated with smoking – a meta-analysis. J Intern Med 2003; 254: 57283.
  • 39
    Black DM, Cummings SR, Kerpf DB et al. Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348: 153541.
  • 40
    Sylvester FA, Wyzga N, Hyams JS, Gronowicz GA. Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6. J Bone Miner Res 2002; 17: 695702.